Study: Alarming surge in cancer cases among young adults

Accoring to a new study, there has been a shocking 79 percent surge in new cancer cases among people under 50, and medical experts are pointing the finger at our diets and fitness levels.

Ozempic maker taking legal action against counterfeit copies

The drugmaker is adamant the deceptive practices not only jeopardize patient well-bein, but also compromise the credibility of their FDA-approved Semaglutide medicines.

Wagovy, Ozempic patients could face higher risk of complications under anesthesia

Drugs like Wegovy and Ozempic can slow digestion so much that it puts patients at increased risk for pulmonary aspiration when they're under anesthesia.

COVID-19 hospitalizations in the US resurge, marked by different patterns

Here we go again: COVID-19 hospital admissions have inched upward in the United States since early July in a small-scale echo of the three previous summers.

Attacks at US medical centers reveal why health care is among nation's most violent fields

Stats from the Bureau of Labor Statistics show that American health care workers are now far more likely to suffer nonfatal injuries by violence than workers in any other profession, including law enforcement.

Employers dropping weight loss drugs from insurance coverage

A new roadblock is cropping up for people on their quest to get popular weight loss drugs Ozempic and Wegovy, as more and more employers are opting to cancel insurance coverage of the pricey injection.

Alzheimer’s drug Leqembi given full FDA approval

Leqembi is the first medicine that’s been convincingly shown to modestly slow the cognitive decline caused by Alzheimer's.

Biden launches new initiatives to reduce health care costs

The plan includes a crackdown on scam insurance plans, new guidance to prevent surprise medical bills and an effort to reduce medical debt tied to credit cards.

Medicaid: More than 1M dropped as states start post-pandemic purge of rolls

States were prohibited from removing people from Medicaid during the pandemic — but that ban was lifted in April. Most got dropped for not filling out paperwork.

NYU Langone sues Northwell over 'similar' purple color used in advertising

The lawsuit alleges Northwell intentionally copied its "unique" color purple, creating what it's attorneys are calling "confusingly similar advertising."